genetic framework improving arrhythmia therapy
abnormalities heart rhythm continue cause high rates illness death better treatment provided solving two main challenges: early identification patients risk characterization molecular pathways culminate arrhythmias analysing mechanisms increase susceptibility arrhythmia individuals genetic syndromes might possible improve current therapies develop new ways treat prevent common arrhythmias
